Online citations, reference lists, and bibliographies.
← Back to Search

Controlled Drug Delivery For Glaucoma Therapy Using Montmorillonite/Eudragit Microspheres As An Ion-exchange Carrier

Shuangyan Tian, J. Li, Q. Tao, Yawen Zhao, Zhufen Lv, Fan Yang, Haoyun Duan, Y. Chen, Q. Zhou, Dongzhi Hou
Published 2018 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Background Glaucoma is a serious eye disease that can lead to loss of vision. Unfortunately, effective treatments are limited by poor bioavailability of antiglaucoma medicine due to short residence time on the preocular surface. Materials and methods To solve this, we successfully prepared novel controlled-release ion-exchange microparticles to deliver betaxolol hydrochloride (BH). Montmorillonite/BH complex (Mt-BH) was prepared by acidification-intercalation, and this complex was encapsulated in microspheres (Mt-BH encapsulated microspheres [BMEMs]) by oil-in-oil emulsion–solvent evaporation method. The BH loaded into ion-exchange Mt was 47.45%±0.54%. After the encapsulation of Mt-BH into Eudragit microspheres, the encapsulation efficiency of BH into Eudragit microspheres was 94.35%±1.01% and BH loaded into Eudragit microspheres was 14.31%±0.47%. Results Both Fourier transform infrared spectra and X-ray diffraction patterns indicated that BH was successfully intercalated into acid-Mt to form Mt-BH and then Mt-BH was encapsulated into Eudragit microspheres to obtain BMEMs. Interestingly, in vitro release duration of the prepared BMEMs was extended to 12 hours, which is longer than both of the BH solution (2.5 hours) and the conventional BH microspheres (5 hours). Moreover, BMEM exhibited lower toxicity than that of BH solution as shown by the results of cytotoxicity tests, chorioallantoic membrane-trypan blue staining, and Draize rabbit eye test. In addition, both in vivo and in vitro preocular retention capacity study of BMEMs showed a prolonged retention time. The pharmacodynamics showed that BMEMs could extend the drug duration of action. Conclusion The developed BMEMs have the potential to be further applied as ocular drug delivery systems for the treatment of glaucoma.
This paper references
10.1016/j.ejpb.2011.11.013
Stimuli-responsive hydrogels for controlled pilocarpine ocular delivery.
M. Casolaro (2012)
10.3109/10837450.2010.508075
Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique
M. Jelvehgari (2011)
10.1016/j.ijpharm.2014.02.032
In vivo evaluation and in-depth pharmaceutical characterization of a rapidly dissolving solid ocular matrix for the topical delivery of timolol maleate in the rabbit eye model.
Raeesa M Moosa (2014)
10.1016/S0142-9612(02)00080-7
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
R. Pignatello (2002)
10.1080/10611860802556842
Mucoadhesive microspheres for nasal administration of cyclodextrins.
E. Gavini (2009)
10.1021/LA00077A017
Texture evolution of montmorillonite under progressive acid treatment: change from H3 to H2 type of hysteresis
S. Mendioroz (1987)
10.2147/IJN.S122747
A novel ion-exchange carrier based upon liposome-encapsulated montmorillonite for ophthalmic delivery of betaxolol hydrochloride
Y. Huang (2017)
10.1016/J.MICROMESO.2011.11.032
Chitosan–montmorillonite bio-based aerogel hybrid microspheres
Hamid Ennajih (2012)
10.1517/17425247.5.6.615
Analysis of initial burst in PLGA microparticles.
S. Allison (2008)
10.1124/jpet.111.190447
Prevention of Trinitrobenzene Sulfonic Acid-Induced Experimental Colitis by Oral Administration of a Poly(lactic-coglycolic Acid) Microsphere Containing Prostaglandin E2 Receptor Subtype 4 Agonist
T. Okamoto (2012)
10.1016/J.ADDR.2007.04.007
Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
A. Almeida (2007)
10.1002/(SICI)1099-1263(199807/08)18:4<233::AID-JAT496>3.0.CO;2-Y
A critical review of the assessment of eye irritation potential using the draize rabbit eye test
M. York (1998)
10.3109/03639045.2011.552908
pH-Sensitive oral insulin delivery systems using Eudragit microspheres
R. C. Mundargi (2011)
10.3109/03639045.2015.1085872
Preparation and evaluation of a timolol maleate drug–resin ophthalmic suspension as a sustained-release formulation in vitro and in vivo
Fuhong Qin (2016)
10.1016/j.ijpharm.2013.07.022
Poly(ester amide) blend microspheres for oral insulin delivery.
P. He (2013)
10.1016/j.ijpharm.2010.01.002
Layered bionanocomposites as carrier for procainamide.
B. Kevadiya (2010)
10.1136/bjo.80.5.389
Number of people with glaucoma worldwide.
H. Quigley (1996)
10.1166/JNN.2012.5832
Characterization and evaluation of poly(epsilon-caprolactone) nanoparticles containing 2-ethylhexyl-p-methoxycinnamate, octocrylene, and benzophenone-3 in anti-solar preparations.
Débora F do Nascimento (2012)
10.1016/j.jconrel.2015.01.023
Sustained drug release by contact lenses for glaucoma treatment-a review.
I. Carvalho (2015)
10.1016/j.ijpharm.2009.03.024
The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles.
Suchada Nilkumhang (2009)
10.1201/9780203008799.ch14
Three-Dimensional Construct of the Human Corneal Epithelium for In Vitro Toxicology
M. Rosdy (2003)
10.1016/J.IJPHARM.2003.09.016
Vesicular systems in ocular drug delivery: an overview.
I. P. Kaur (2004)
10.1006/EXER.1996.0184
A rat model of chronic pressure-induced optic nerve damage.
J. Morrison (1997)
10.1016/0887-2333(91)90006-Y
Quantitative evaluation to predict the eye irritancy of chemicals: Modification of chorioallantoic membrane test by using trypan blue.
S. Hagino (1991)
10.4236/ANP.2015.43009
Preparation and Characterization of Novel Drug-Inserted-Montmorillonite Chitosan Carriers for Ocular Drug Delivery
Dongzhi Hou (2015)
10.2147/IJN.S25468
Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye
Jayaganesh V. Natarajan (2012)
10.2147/IJN.S44487
Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation
Yikang Dai (2013)
10.2147/IJN.S16043
Synthesis and characterization of silver/montmorillonite/chitosan bionanocomposites by chemical reduction method and their antibacterial activity
K. Shameli (2011)
10.1039/C1NJ20672A
Synthesis and characterization of a novel pH-controllable composite hydrogel for anticancer drug delivery
T. Anirudhan (2011)
10.1016/j.nano.2009.10.004
Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery.
H. Gupta (2010)
10.1016/J.CLAY.2007.01.012
Study on ibuprofen/montmorillonite intercalation composites as drug release system
J. Zheng (2007)
Sparfloxacinloaded PLGA nanoparticles for sustained ocular drug
H Gupta (2010)
10.1001/ARCHOPHT.125.8.1010
Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure.
S. Hong (2007)
10.1001/ARCHOPHT.1997.01100160145002
Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma.
A. Konstas (1997)
10.1039/c2nr30924f
Diclofenac/biodegradable polymer micelles for ocular applications.
X. Li (2012)
10.1089/108076802321021036
Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients.
F. A. Medeiros (2002)
10.1016/J.CLAY.2015.10.028
Preparation and in vitro study of lipid nanoparticles encapsulating drug loaded montmorillonite for ocular delivery
Dongzhi Hou (2016)
10.1016/S0928-0987(02)00057-X
Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
R. Pignatello (2002)
10.1016/0169-409X(95)00017-2
Microspheres and nanoparticles used in ocular delivery systems
A. Zimmer (1995)
10.1007/BF02980037
Control of encapsulation efficiency and initial burst in polymeric microparticle systems
Yoon Yeo (2004)
10.3109/10717544.2013.843608
Pharmacodynamics of diclofenac from novel Eudragit entrapped microspheres
M. Momoh (2014)
10.1016/J.BIOMATERIALS.2005.03.021
Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Yuancai Dong (2005)
10.2147/dddt.s76676
Development of lovastatin-loaded poly(lactic acid) microspheres for sustained oral delivery: in vitro and ex vivo evaluation
Qigang Guan (2015)
10.1016/J.IJPHARM.2003.09.015
Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide.
S. Haznedar (2004)
10.2147/IJN.S63414
Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions
Wen-ji Zhang (2014)
10.1016/S0887-2333(00)00050-3
The quantitive chlorioallantoic membrane test using trypan blue stain to predict the eye irritancy of liquid scintillation cocktails.
M. Vinardell (2000)
10.1016/j.jconrel.2015.05.279
Novel biodegradable polyesteramide microspheres for controlled drug delivery in Ophthalmology.
V. Andrés-Guerrero (2015)
10.1016/j.carbpol.2015.03.064
Chitosan-Montmorillonite microspheres: A sustainable fertilizer delivery system.
Bruna Rodrigues dos Santos (2015)
10.1016/j.ejps.2010.02.002
Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride.
Yeamin Huh (2010)
10.1016/J.MINPRO.2011.04.011
Kinetic analysis of 2,4,5-trichlorophenol adsorption onto acid-activated montmorillonite from aqueous solution
H. Zaghouane-Boudiaf (2011)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar